Compare TRGS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRGS | CATX |
|---|---|---|
| Founded | 2025 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.8M | 113.9M |
| IPO Year | 2026 | 2018 |
| Metric | TRGS | CATX |
|---|---|---|
| Price | $10.01 | $0.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $9.43 |
| AVG Volume (30 Days) | 28.4K | ★ 4.4M |
| Earning Date | N/A | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $91.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.88 | $0.73 |
| 52 Week High | $10.03 | $6.16 |
| Indicator | TRGS | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 61.74 | 24.60 |
| Support Level | N/A | N/A |
| Resistance Level | $10.03 | $2.40 |
| Average True Range (ATR) | 0.00 | 0.11 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 76.92 | 5.72 |
TRG Latin America Acquisitions Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.